Esophageal stricture
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Esophageal stricture is the result of increased pressure of lower esophageal sphincter. It is associated with disorders such as gastroesophageal reflux disease, esophageal motor disorders, inflammation and fibrosis in neoplasia. Common causes of esophageal stricture include gastroesophageal reflux disease and caustic ingestions. Overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states.The most potent risk factor in the development of esophageal stricture is frequent acid reflux. Esophageal stricture is diagnosed based on history of dysphagia and diagnostic studies such as barium esophagography, esophagogastroduodenoscopy, endoscopic ultrasound, and manometry. Pharmacologic medical therapy for esophageal stricture secondary to gastroesophageal reflux disease includes proton pump inhibitors or H2 antagonists. The mainstay of treatment for esophageal stricture is dilation. Self-expandable plastic or metal stents placement is indicated for patients with refractory esophageal stricture. Surgery is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of dysphagia, extraesophageal manifestations and long term side effects of medical therapy.
Historical Perspective
The first intervention for esophageal stricture was done in the 17th century by Whalebone. The first bougienage was performed in 1801. In 1868, esophagoscope was developed for the first time. In 1877, first surgical resection for esophageal carcinoma was performed by Vincenz Czerny. The first stent was introduced in 1990.
Classification
There is no established system for the classification of esophageal stricture, but it may be classified into benign and malignant according to causes.
Pathophysiology
Esophageal stricture is the result of lower pressure of esophageal sphincter in gastroesophageal reflux disease, esophageal motor disorder, inflammation and fibrosis in neoplasia. The most characteristic finding in gross pathology is thickening of the lower esophageal wall in gastroesophageal reflux disease, a pale mucosa in lymphocytic esophagitis and hemorrhagic congestion in caustic ingestion. Microscopic histopathological characteristic findings of esophageal stricture is intraepithelial lymphocytosis, basal cell hyperplasia in gastroesophageal reflux disease, T lymphocytes infiltration in squamous mucosa in lymphocytic esophagitis and eosinophilic necrosis in caustic ingestion
Causes
Common causes of esophageal stricture include gastroesophageal reflux disease and caustic ingestions.
Differentiating esophageal stricture from Other Diseases
Esophageal stricture must be differentiated from Plummer-Vinson syndrome, achalasia, diffuse esophageal spasm, systemic sclerosis, zenker’s diverticulum, esophageal carcinoma, stroke, motor disorders such as Myasthenia Gravis, GERD, esophageal web.
Epidemiology and Demographics
Most of the esophageal strictures are related to gastroesophageal reflux disease. The overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. The incidence of esophageal stricture increases with age. There is no racial predilection to esophageal stricture. The risk of esophageal stricture is higher in men under 60 years but there is similar incidence in men and women after age 60.
Risk Factors
The most potent risk factor in the development of esophageal stricture is frequent acid reflux. Other risk factors include hiatal hernia, obesity, smoking, esophageal dysmotility, increased gastric acidity, and heavy alcohol use.
Screening
There is insufficient evidence to recommend routine screening for esophageal stricture.
Natural History, Complications, and Prognosis
If left untreated, patients with esophageal stricture may progress to develop pulmonary aspiration, weight loss, and dehydration. Common complications of esophageal stricture include perforation, bleeding, pneumonia and bacteremia. Prognosis is generally good but recurrence of symptoms after dilation are prevalent and usually recurrent dilation is necessary.
Diagnosis
Diagnostic study of choice
Esophageal stricture is diagnosed based on history of dysphagia and diagnostic studies such as barium esophagography, esophagogastroduodenoscopy, endoscopic ultrasound and manometry.
History and Symptoms
The hallmark of esophageal stricture is dysphagia . A positive history of heartburn is suggestive of esophageal stricture. The most common symptoms of esophageal stricture include dysphagia, odynophagia, and heartburn. Less common symptoms of esophageal stricture include chronic cough and wheezing.
Physical Examination
Patients with esophageal stricture can usually appear normal. Cachexia and pallor are notable in patients with esophageal stricture due to neoplastic causes.
Laboratory Findings
Laboratory findings are usually normal among patients with esophageal stricture although anemia may be seen with neoplastic causes of esophageal stricture. Other possible laboratory tests are high serum gastrin level in zollinger ellison syndrome and peripheral eosinophilia in eosinophilic esophagitis as causes of esophageal stricture.
Electrocardiogram
There are no ECG findings associated with esophageal stricture.
X-ray
A chest x-ray may be helpful in the diagnosis of tumors as a cause of esophageal stricture.
CT scan
Chest CT scan may be helpful in the diagnosis of malignant causes of esophageal stricture.
MRI
In general MRI has not been routinely recommended for esophageal stricture.
Echocardiography or Ultrasound
There are no echocardiography findings associated with esophageal stricture. Endoscopic ultrasound may be helpful in the diagnosis of malignant causes of esophageal stricture.
Other Imaging Findings
Barium esophagography is helpful in the diagnosis of esophageal stricture. Findings on a barium esophagogram suggestive of benign esophageal stricture include concentric narrowing and smooth tapering. Eccentric narrowing, abrupt and asymmetric narrowing are suggestive of malignant causes.
Other Diagnostic Studies
Other diagnostic studies for esophageal stricture include esophagogastroduodenoscopy (EGD) for detection malignant causes. Manometry is used in cases of esophageal stricture due to dysmotility.
Treatment
Medical Therapy
Pharmacologic medical therapy for esophageal stricture secondary to gastroesophageal reflux disease includes proton pump inhibitors or H2 antagonists. Patients are advised to consider life style modification for gastroesophageal reflux disease.
Surgery
The mainstay of treatment for esophageal stricture is dilation. Self-expandable plastic or metal stents placement is indicated for patients with refractory esophageal stricture.
Surgery is usually reserved for patients with either inability to dilate the stricture, frequent recurrence of dysphagia, extraesophageal manifestations and long term side effects of medical therapy
Primary Prevention
Effective measures for the primary prevention of esophageal stricture include treatment and life style modification for gastroesophageal reflux disease, taking pills with a full glass of water and storing all corrosive chemicals.
Secondary Prevention
Effective measures for the secondary prevention of esophageal stricture include lifestyle modification, proton pump inhibitors or H2 antagonists.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
The first intervention for esophageal stricture was done in the 17th century by halebone. The first bougienage was performed in 1801. In 1868, esophagoscope was developed for the first time. In 1877, first surgical resection for esophageal carcinoma was performed by Vincenz Czerny. The first stent was introduced in 1990.
Outbreaks
There have been no outbreaks of esophageal stricture.
Landmark Events in the Development of Treatment Strategies
- Esophageal dialtion was first done in the 17 century by a curved whalebone.[1]
- In 1801, the first bougienage was performed by Alexis Boyer.[1]
- In 1868, esophagoscope was developed by Adolf Kussmaul to diagnose esophageal cancer as a one of the most causes of esophageal stricture.[2]
- In 1877, first resection of the cervical esophagus for carcinoma was performed by Vincenz Czerny.[2]
- In 1913, the first subtotal thoracic esophagectomy was performed by Franz Torek.[2]
- In 1913, the first esophagectomy with an intrathoracic esophagogastric anastomosis was performed by Tohru Ohsawa.[2]
- In 1966, steroid injection added to endoscopic dilation to prevent stricture recurrence.[3]
- In 1990, the first self expandable metal stent was introduced.[4]
Famous Cases
- The following are a few famous cases of esophageal stricture due to esophageal carcinoma:
- Humphrey DeForest Bogart
- Christopher Eric Hitchens
- Ron Silver
- Richard Dawson
- Jean Hagen
- Sylvia Maria Kristel
References
- ↑ 1.0 1.1 Lew RJ, Kochman ML (2002). “A review of endoscopic methods of esophageal dilation”. J. Clin. Gastroenterol. 35 (2): 117–26. PMID 12172355.
- ↑ 2.0 2.1 2.2 2.3 Karamanou M, Markatos K, Papaioannou TG, Zografos G, Androutsos G (2017). “Hallmarks in history of esophageal carcinoma”. J BUON. 22 (4): 1088–1091. PMID 28952239.
- ↑ Ashcraft KW, Holder TM (1969). “The expeimental treatment of esophageal strictures by intralesional steroid injections”. J. Thorac. Cardiovasc. Surg. 58 (5): 685–91 passim. PMID 5348158.
- ↑ Martinez JC, Puc MM, Quiros RM (2011). “Esophageal stenting in the setting of malignancy”. ISRN Gastroenterol. 2011: 719575. doi:10.5402/2011/719575. PMC 3168502. PMID 21991527.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There is no established system for the classification of esophageal stricture, but it may be classified into benign and malignant according to causes.
Classification
There is no established system for the classification of esophageal stricture, however it may be classified according to etiologic causes into benign and malignant. [1][2][3][4][5]
| Esophageal stricture | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Benign | Malignant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| GERD | Chemical induced | Iatrogenic | Esophagitis | Dyskeratosis congenita (DC) | Esophageal cancer | Malignant transformation due to DC | Extrinsic compression due to malignant tumors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Idiopathic | Drug induced | Infections | Congenital | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eosinophilic | Lymphocytic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Furuta, Glenn T.; Ingelfinger, Julie R.; Katzka, David A. (2015). “Eosinophilic Esophagitis”. New England Journal of Medicine. 373 (17): 1640–1648. doi:10.1056/NEJMra1502863. ISSN 0028-4793.
- ↑ Marks RD, Richter JE (1993). “Peptic strictures of the esophagus”. Am. J. Gastroenterol. 88 (8): 1160–73. PMID 8338082.
- ↑ Wasserman RL, Ginsburg CM (1985). “Caustic substance injuries”. J. Pediatr. 107 (2): 169–74. PMID 4020540.
- ↑ Coia LR, Myerson RJ, Tepper JE (1995). “Late effects of radiation therapy on the gastrointestinal tract”. Int. J. Radiat. Oncol. Biol. Phys. 31 (5): 1213–36. doi:10.1016/0360-3016(94)00419-L. PMID 7713784.
- ↑ Khanna N (2006). “How do I dilate a benign esophageal stricture?”. Can J Gastroenterol. 20 (3): 153–5. PMC 2582967. PMID 16550258.
- ↑ Guynn TP, Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Nostrant TT, Elta GH, Barnett JL (1991). “Injection sclerotherapy-induced esophageal strictures. Risk factors and prognosis”. Am Surg. 57 (9): 567–71, discussion 571–2. PMID 1928999.
- ↑ Furuta, Glenn T.; Ingelfinger, Julie R.; Katzka, David A. (2015). “Eosinophilic Esophagitis”. New England Journal of Medicine. 373 (17): 1640–1648. doi:10.1056/NEJMra1502863. ISSN 0028-4793.
- ↑ Goenka MK, Gupta NM, Kochhar R, Rungta U, Vaiphei K, Nagi B, Suri S (1995). “Mediastinal fibrosis: an unusual cause of esophageal stricture”. J. Clin. Gastroenterol. 20 (4): 331–3. PMID 7665827.
- ↑ Bonavina L, DeMeester TR, McChesney L, Schwizer W, Albertucci M, Bailey RT (1987). “Drug-induced esophageal strictures”. Ann Surg. 206 (2): 173–83. PMC 1493104. PMID 3606243.
- ↑ Wilcox CM (2013). “Overview of infectious esophagitis”. Gastroenterol Hepatol (N Y). 9 (8): 517–9. PMC 3980995. PMID 24719600.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Esophageal stricture is the result of lower pressure of esophageal sphincter in gastroesophageal reflux disease, esophageal motor disorder, and inflammation and fibrosis in neoplasia. The characteristic findings on gross pathology are thickening of the lower esophageal wall in gastroesophageal reflux disease, pale mucosa in lymphocytic esophagitis, and hemorrhagic congestion in caustic ingestion. Characteristic histopathological findings of esophageal stricture are intraepithelial lymphocytosis and basal cell hyperplasia in gastroesophageal reflux disease; T lymphocyte infiltration in squamous mucosa in lymphocytic esophagitis and eosinophilic necrosis in caustic ingestion.
Pathophysiology
Pathogenesis
![]() |
The normal esophageal diameter is up to 30 mm. An esophageal stricture is a narrowing of the esophagus usually 13 mm or less in diameter that causes dysphagia. Peptic strictures occur usually at the squamocolumnar junction.[2]
Esophageal stricture is the result of:[3][4]
- Lower pressure of esophageal sphincter in gastroesophageal reflux disease
- Esophageal motor disorders
- Inflammation and fibrosis due to intrinsic diseases of esophagus, such as neoplasia
- Surgical esophageal anastomosis
- Esophageal compression by other organs
- Most peptic strictures are result of chronic reflux esophagitis and the process of esophageal stricture is due to mucosal edema and infiltration of inflammatory cells in lamina propria and finally collagen deposits, fibrosis and scar of esophagus.[2]
- Lower esophageal sphincter (LES) tone is usually less than 8 mmHg in esophageal stricture due to reflux esophagitis.
- Radiation therapy for thoracic or head and neck tumors is one of the less common cause of proximal esophageal stricture by inducing chronic ischemia and fibrosis.[5]
- Liquefactive necrosis is the mechanism of esophageal stricture in alkali ingestion and superficial coagulation necrosis is the mechanism of esophageal stricture in acid ingestion.[6][7]
- A grading system for esophageal injury due to caustic ingestion:
| Grade | pathophysiological injury |
|---|---|
| 0 | Normal |
| 1 | Mucosal edema and hyperemia |
| 2A | Superficial ulcers, bleeding, exudates |
| 2B | Deep focal or circumferential ulcers |
| 3A | Focal necrosis |
| 3B | Extensive necrosis |
Genetics
Genes involved in the pathogenesis of esophageal stricture due to Dyskeratosis Congenita include:[8]
Associated Conditions
- The most important diseases associated with esophageal stricture include:
- Gastroesophageal reflux disease
- Caustic ingestion
Gross Pathology
- On gross pathology, circumferential thickening of the lower esophageal wall are characteristic finding of esophageal stricture due to gastroesophageal reflux disease.[9]
- Pale mucosa with white exudate in lymphocytic esophagitis[10]
- Swelling and hemorrhagic congestion in caustic ingestion[11]
- Multiple yellow plaques in infectious esophagitis due to Candida[12]
- Ulceration of the esophagus in viral esophagitis
Microscopic Pathology
![]() ![]() |
- On microscopic histopathological analysis, characteristic findings of esophageal stricture due to gastroesophageal reflux disease are:[15]
- Intraepithelial lymphocytosis
- Basal cell hyperplasia
- Ulceration [9]
- Microscopic histopathological characteristic findings of esophageal stricture due to lymphocytic esophagitis are:[10]
- Infiltration of many CD3+ /CD4+ / CD8+ T lymphocytes in squamous mucosa in the peripapaillary region without any granulocytes
- Eosinophilic necrosis in esophageal stricture due to caustic ingestion[11]
References
- ↑ From en.wikipedia.org, Public Domain, <“https://commons.wikimedia.org/w/index.php?curid=1931423“>
- ↑ 2.0 2.1 Marks RD, Richter JE (1993). “Peptic strictures of the esophagus”. Am. J. Gastroenterol. 88 (8): 1160–73. PMID 8338082.
- ↑ Holzheimer, R (2001). Surgical treatment : evidence-based and problem-oriented. München New York: Zuckschwerdt. ISBN 3-88603-714-2.
- ↑ Belevich VL, Ovchinnikov DV (2013). “[Treatment of benign esophageal stricture]”. Vestn. Khir. Im. I. I. Grek. (in Russian). 172 (5): 111–4. PMID 24640761.
- ↑ Dhir V, Vege SS, Mohandas KM, Desai DC (1996). “Dilation of proximal esophageal strictures following therapy for head and neck cancer: experience with Savary Gilliard dilators”. J Surg Oncol. 63 (3): 187–90. doi:10.1002/(SICI)1096-9098(199611)63:3<187::AID-JSO10>3.0.CO;2-2. PMID 8944064.
- ↑ Fisher RA, Eckhauser ML, Radivoyevitch M (1985). “Acid ingestion in an experimental model”. Surg Gynecol Obstet. 161 (1): 91–9. PMID 4012549.
- ↑ Zargar SA, Kochhar R, Nagi B, Mehta S, Mehta SK (1992). “Ingestion of strong corrosive alkalis: spectrum of injury to upper gastrointestinal tract and natural history”. Am. J. Gastroenterol. 87 (3): 337–41. PMID 1539568.
- ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Mefford HC, Stephens K, Amemiya A, Ledbetter N, Savage SA. PMID 20301779. Vancouver style error: initials (help); Missing or empty
|title=(help) - ↑ 9.0 9.1 Yamasaki, Yasushi; Ozawa, Soji; Oguma, Junya; Kazuno, Akihito; Ninomiya, Yamato (2016). “Long peptic strictures of the esophagus due to reflux esophagitis: a case report”. Surgical Case Reports. 2 (1). doi:10.1186/s40792-016-0190-1. ISSN 2198-7793.
- ↑ 10.0 10.1 Maejima, Ryuhei; Uno, Kaname; Iijima, Katsunori; Fujishima, Fumiyoshi; Noguchi, Tetsuya; Ara, Nobuyuki; Asano, Naoki; Koike, Tomoyuki; Imatani, Akira; Shimosegawa, Tooru (2016). “A Japanese case of lymphocytic esophagitis”. Digestive Endoscopy. 28 (4): 476–480. doi:10.1111/den.12578. ISSN 0915-5635.
- ↑ 11.0 11.1 Contini, Sandro (2013). “Caustic injury of the upper gastrointestinal tract: A comprehensive review”. World Journal of Gastroenterology. 19 (25): 3918. doi:10.3748/wjg.v19.i25.3918. ISSN 1007-9327.
- ↑ Wilcox CM (2013). “Overview of infectious esophagitis”. Gastroenterol Hepatol (N Y). 9 (8): 517–9. PMC 3980995. PMID 24719600.
- ↑ <“https://commons.wikimedia.org/wiki/File%3ATinci%C3%B3n_hematoxilina-eosina.jpg“> via Wikimedia Commons
- ↑ “https://commons.wikimedia.org/wiki/File%3AGastroesophageal_reflux_disease_–_low_mag.jpg“>via Wikimedia Commons
- ↑ “Esophageal stricture – Libre Pathology”.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Common causes of esophageal stricture include gastroesophageal reflux disease and caustic ingestions.
Causes
Life-threatening Causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no life-threatening causes of esophageal stricture, however complications resulting from untreated esophageal stricture is common.
Common Causes
Esophageal stricture may be caused by:[1]
- Gastroesophageal reflux disease[2]
- Caustic ingestions[3]
- Radiation therapy for thoracic or head and neck tumors[4]
- Esophageal cancer
- Congenital causes such as rings and webs[5]
- Nasogastric intubation[6]
Less Common Causes
Less common causes of esophageal stricture include:
- Dyskeratosis congenita (DC)[9]
- Rare dermatologic diseases (eg, epidermolysis bullosa dystrophica)[10]
- Mediastinal fibrosis due to tuberculosis or idiopathic fibrosing mediastinitis[11]
- Drug-induced stricture:[12]
- Aspirin and anti-inflammatory medications[13]
- Tetracycline
- Doxycycline
- Clindamycin
- Bisphosphonates
- Potassium chloride
- Quinidine preparations
- Iron compounds
- Emepronium
- Alprenolol
- Pinaverium
- Tracheoesophageal fistula repair and esophageal stricture at the anastomosis[15]
- Esophageal diverticula[16]
- Increased level of gastric acid exposure to esophageal tissue, for example:
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | Caustic ingestion |
| Dental | No underlying causes |
| Dermatologic | Dyskeratosis congenita (DC), epidermolysis bullosa dystrophica |
| Drug Side Effect | Drug-induced stricture:[12]
|
| Ear Nose Throat | No underlying causes |
| Endocrine | Zollinger-Ellison syndrome, |
| Environmental | No underlying causes |
| Gastroenterologic | Gastroesophageal reflux disease, Eosinophilic esophagitis, Esophageal diverticula, Zollinger-Ellison syndrome, Systemic sclerosis |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | Previous surgery on the esophagus, Radiation therapy for thoracic or head and neck tumors, Esophageal sclerotherapy,Tracheoesophageal fistula repair, Nasogastric tube placement, Heller myotomy for achalasia |
| Infectious Disease | Infectious esophagitis
|
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | Mediastinal fibrosis due to tuberculosis or idiopathic fibrosing mediastinitis |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | Systemic sclerosis |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the disease in alphabetical order.
- Caustic ingestions
- Drug-induced stricture
- Dyskeratosis congenita (DC)
- Eosinophilic esophagitis
- Esophageal diverticula
- Esophageal sclerotherapy
- Gastroesophageal reflux disease
- Increased level of gastric acid exposure to esophageal tissue
- Infectious esophagitis
- Mediastinal fibrosis due to tuberculosis or idiopathic fibrosing mediastinitis
- Nasogastric intubation
- Radiation therapy for thoracic or head and neck tumors
- Rare dermatologic diseases (eg, epidermolysis bullosa dystrophica)
- Tracheoesophageal fistula repair and esophageal stricture at the anastomosis
References
- ↑ Csendes A, Braghetto I (1992). “Surgical management of esophageal strictures”. Hepatogastroenterology. 39 (6): 502–10. PMID 1483661.
- ↑ Marks RD, Richter JE (1993). “Peptic strictures of the esophagus”. Am. J. Gastroenterol. 88 (8): 1160–73. PMID 8338082.
- ↑ Wasserman RL, Ginsburg CM (1985). “Caustic substance injuries”. J. Pediatr. 107 (2): 169–74. PMID 4020540.
- ↑ Coia LR, Myerson RJ, Tepper JE (1995). “Late effects of radiation therapy on the gastrointestinal tract”. Int. J. Radiat. Oncol. Biol. Phys. 31 (5): 1213–36. doi:10.1016/0360-3016(94)00419-L. PMID 7713784.
- ↑ Khanna N (2006). “How do I dilate a benign esophageal stricture?”. Can J Gastroenterol. 20 (3): 153–5. PMC 2582967. PMID 16550258.
- ↑ Luedtke P, Levine MS, Rubesin SE, Weinstein DS, Laufer I (2003). “Radiologic diagnosis of benign esophageal strictures: a pattern approach”. Radiographics. 23 (4): 897–909. doi:10.1148/rg.234025717. PMID 12853664.
- ↑ Guynn TP, Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Nostrant TT, Elta GH, Barnett JL (1991). “Injection sclerotherapy-induced esophageal strictures. Risk factors and prognosis”. Am Surg. 57 (9): 567–71, discussion 571–2. PMID 1928999.
- ↑ Furuta, Glenn T.; Ingelfinger, Julie R.; Katzka, David A. (2015). “Eosinophilic Esophagitis”. New England Journal of Medicine. 373 (17): 1640–1648. doi:10.1056/NEJMra1502863. ISSN 0028-4793.
- ↑ Jonassaint NL, Guo N, Califano JA, Montgomery EA, Armanios M (2013). “The gastrointestinal manifestations of telomere-mediated disease”. Aging Cell. 12 (2): 319–23. doi:10.1111/acel.12041. PMC 3602337. PMID 23279657.
- ↑ Guerra-Leal JD, Meester I, Cantu-Gonzalez JR, Ornelas-Cortinas G, Montemayor-Martinez A, Salas-Alanis JC (2016). “The Importance of Esophagography in Patients With Recessive Dystrophic Epidermolysis Bullosa”. AJR Am J Roentgenol: 1–4. doi:10.2214/AJR.16.16115. PMID 27384758.
- ↑ Goenka MK, Gupta NM, Kochhar R, Rungta U, Vaiphei K, Nagi B, Suri S (1995). “Mediastinal fibrosis: an unusual cause of esophageal stricture”. J. Clin. Gastroenterol. 20 (4): 331–3. PMID 7665827.
- ↑ 12.0 12.1 Bonavina L, DeMeester TR, McChesney L, Schwizer W, Albertucci M, Bailey RT (1987). “Drug-induced esophageal strictures”. Ann Surg. 206 (2): 173–83. PMC 1493104. PMID 3606243.
- ↑ 13.0 13.1 Kikendall JW, Friedman AC, Oyewole MA, Fleischer D, Johnson LF (1983). “Pill-induced esophageal injury. Case reports and review of the medical literature”. Dig. Dis. Sci. 28 (2): 174–82. PMID 6825537.
- ↑ Wilcox CM (2013). “Overview of infectious esophagitis”. Gastroenterol Hepatol (N Y). 9 (8): 517–9. PMC 3980995. PMID 24719600.
- ↑ Lakoma A, Fallon SC, Mathur S, Kim ES (2013). “Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair”. European J Pediatr Surg Rep. 1 (1): 24–6. doi:10.1055/s-0033-1341418. PMC 4335951. PMID 25755944.
- ↑ Smith, C. Daniel (2015). “Esophageal Strictures and Diverticula”. Surgical Clinics of North America. 95 (3): 669–681. doi:10.1016/j.suc.2015.02.017. ISSN 0039-6109.
- ↑ Ebert, Ellen C. (2008). “Esophageal disease in progressive systemic sclerosis”. Current Treatment Options in Gastroenterology. 11 (1): 64–69. doi:10.1007/s11938-008-0008-8. ISSN 1092-8472.
- ↑ 18.0 18.1 Luedtke, Pia; Levine, Marc S.; Rubesin, Stephen E.; Weinstein, Donald S.; Laufer, Igor (2003). “Radiologic Diagnosis of Benign Esophageal Strictures: A Pattern Approach”. RadioGraphics. 23 (4): 897–909. doi:10.1148/rg.234025717. ISSN 0271-5333.
- ↑ Ferguson MK (1991). “Achalasia: current evaluation and therapy”. Ann. Thorac. Surg. 52 (2): 336–42. PMID 1863166.
Differentiating Esophageal stricture from other Disorders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Esophageal stricture must be differentiated from Plummer-Vinson syndrome, achalasia, diffuse esophageal spasm, systemic sclerosis, zenker’s diverticulum, esophageal carcinoma, stroke, motor disorders, GERD, esophageal web.
Differentiating Esophageal stricture from other Diseases
- Esophageal stricture must be differentiated from other diseases that cause dysphagia such as Plummer-Vinson syndrome, achalasia , diffuse esophageal spasm, systemic sclerosis, zenker’s diverticulum, esophageal carcinoma, stroke(cerebral hemorrhage), motor disorders (Myasthenia Gravis), GERD, esophageal web.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Table
| Disease | Signs and Symptoms | Barium esophagogram | Endoscopy | Other imaging and laboratory findings | Gold Standard | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onset | Dysphagia | Weight loss | Heartburn | Other findings | Mental status | |||||||
| Solids | Liquids | Type | ||||||||||
| Plummer-Vinson syndrome |
|
+ | – | Non progressive | +/- | – | Normal |
![]() |
{{#ev:youtube|HFfsTgsB6Pg}}
|
|
Triad of | |
| Esophageal stricture |
|
+ | – | Progressive | +/- | +/- | Normal |
![]() |
{{#ev:youtube|-vax5E-jMnQ}}
|
|
||
| Diffuse esophageal spasm |
|
+ | + | Non progressive | + | + | Normal |
![]() Source:By Nevit Dilmen [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0) |
{{#ev:youtube|2ipA34iMA3c}}
|
|
||
| Achalasia |
|
+ | + | Non progressive | +/- | – |
|
Normal |
![]() |
{{#ev:youtube|ydLcskQzEjM}}
|
||
| Systemic sclerosis |
|
+ | + | Progressive | +/- | + |
|
Normal |
|
|
Positive serology for | |
| Zenker’s diverticulum |
|
+ | – | +/- | – |
|
Normal |
![]() |
{{#ev:youtube|FdEruFsNdVA}}
|
| ||
| Esophageal carcinoma |
|
+ | + | Progressive | + | +/- | Normal |
![]() |
{{#ev:youtube|5ucSlgqGAno}}
|
|||
| Stroke |
|
+ | + | Progressive | + | +/- |
|
Impaired |
|
|
||
| Motor disorders |
|
+ | + | Progressive | +/- | Normal |
|
|
|
| ||
| GERD |
|
+ | – | Progressive | +/- | + | Normal |
|
|
| ||
| Esophageal web |
|
+ | +/- | Progressive | – | +/- |
|
Normal |
|
|
|
|
| Manifestations | Diagnostic tools | |
|---|---|---|
| Achalasia |
|
![]() |
| GERD |
|
![]() |
| Esophageal carcinoma |
|
![]() |
| Corckscrew esophagus |
![]() | |
| Esophageal stricture |
|
![]() |
| Plummer-Vinson syndrome | Common symptoms of Plummer-Vinson syndrome include:[9][10][11]
Less common symptoms
|
Lab tests are consistent with the diagnosis of iron deficiency anemia.
Findings on an x-ray (barium esophagogram) suggestive of esophageal web/strictures associated with Plummer-Vinson syndrome appear as either:
![]() |
References
- ↑ Ferri, Fred (2015). Ferri’s clinical advisor 2015 : 5 books in 1. Philadelphia, PA: Elsevier/Mosby. ISBN 978-0323083751.
- ↑ 2.0 2.1 2.2 Boeckxstaens GE, Zaninotto G, Richter JE (2013). “Achalasia”. Lancet. doi:10.1016/S0140-6736(13)60651-0. PMID 23871090.
- ↑ Badillo R, Francis D (2014). “Diagnosis and treatment of gastroesophageal reflux disease”. World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
- ↑ 4.0 4.1 Napier KJ, Scheerer M, Misra S (2014). “Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities”. World J Gastrointest Oncol. 6 (5): 112–20. doi:10.4251/wjgo.v6.i5.112. PMC 4021327. PMID 24834141.
- ↑ Matsuura H (2017). “Diffuse Esophageal Spasm: Corkscrew Esophagus”. Am. J. Med. doi:10.1016/j.amjmed.2017.08.041. PMID 28943381.
- ↑ Lassen JF, Jensen TM (1992). “[Corkscrew esophagus]”. Ugeskr. Laeg. (in Danish). 154 (5): 277–80. PMID 1736462.
- ↑ Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Eklund S (2006). “Esophageal stricture: incidence, treatment patterns, and recurrence rate”. Am. J. Gastroenterol. 101 (12): 2685–92. doi:10.1111/j.1572-0241.2006.00828.x. PMID 17227515.
- ↑ Shami VM (2014). “Endoscopic management of esophageal strictures”. Gastroenterol Hepatol (N Y). 10 (6): 389–91. PMC 4080876. PMID 25013392.
- ↑ López Rodríguez MJ, Robledo Andrés P, Amarilla Jiménez A, Roncero Maíllo M, López Lafuente A, Arroyo Carrera I (2002). “Sideropenic dysphagia in an adolescent”. J. Pediatr. Gastroenterol. Nutr. 34 (1): 87–90. PMID 11753173.
- ↑ Chisholm M (1974). “The association between webs, iron and post-cricoid carcinoma”. Postgrad Med J. 50 (582): 215–9. PMC 2495558. PMID 4449772.
- ↑ Larsson LG, Sandström A, Westling P (1975). “Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden”. Cancer Res. 35 (11 Pt. 2): 3308–16. PMID 1192404.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
Most of the esophageal strictures are related to gastroesophageal reflux disease. The overall incidence of esophageal stricture is approximately 11 per 100,000 individuals and the prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. The incidence of esophageal stricture increases with age. There is no racial predilection to esophageal stricture. The risk of esophageal stricture is higher in men under 60 years but there is similar incidence in men and women after age 60.
Epidemiology and Demographics
Incidence
- In one study the overall incidence of esophageal stricture is approximately 11 per 100,000 individuals. The incidence of benign esophageal stricture was 8 per 100,000 individuals and malignant stricture was 3 per 100,000 individuals.[1]
- 60–70% of benign strictures of the esophagus are related to gastroesophageal reflux disease.[2]
- Incidence of benign esophageal stricture decreased in recent years because of using proton pump inhibitor (PPI) for treatment of gastroesophageal reflux disease.
Prevalence
- The prevalence of esophageal stricture is approximately 70-120 per 100,000 individuals in united states. [3]
- In Hong kong, the prevalence of benign esophageal stricture was estimated to be 80 cases per 100,000 individuals.[4]
Case-fatality rate/Mortality rate
- Mortality rate of esophageal stricture due to benign causes is not increased compare to normal population, but malignant causes and complications after procedures such as dilation of esophageal stricture can increase mortality.[1]
Age
- The incidence of esophageal stricture increases with age in both of benign and malignant strictures.[1]
Race
- There is no racial predilection to esophageal stricture. Frequency of esophageal stricture was similar in African Americans and non-Hispanic whites.[5]
Gender
- The risk of esophageal stricture due to gastroesophageal reflux disease is higher in men in age group under 60 yr but similar incidence of esophageal stricture in men and women beyond age 60. [1]
References
- ↑ 1.0 1.1 1.2 1.3 Ruigómez, Ana; Alberto García Rodríguez, Luis; Wallander, Mari-Ann; Johansson, Saga; Eklund, Stefan (2006). “Esophageal Stricture: Incidence, Treatment Patterns, and Recurrence Rate”. The American Journal of Gastroenterology. 101 (12): 2685–2692. doi:10.1111/j.1572-0241.2006.00828.x. ISSN 0002-9270.
- ↑ Spechler SJ (1999). “AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus”. Gastroenterology. 117 (1): 233–54. PMID 10381933.
- ↑ Fennerty MB (2003). “The continuum of GERD complications”. Cleve Clin J Med. 70 Suppl 5: S33–50. PMID 14705380.
- ↑ Wong WM, Lam SK, Hui WM, Lai KC, Chan CK, Hu WH, Xia HH, Hui CK, Yuen MF, Chan AO, Wong BC (2002). “Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese–prevalence and spectrum of the disease”. Aliment. Pharmacol. Ther. 16 (12): 2037–42. PMID 12452935.
- ↑ Vega KJ, Chisholm S, Jamal MM (2009). “Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites”. World J. Gastroenterol. 15 (23): 2878–81. PMC 2699005. PMID 19533809.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
The most potent risk factor in the development of esophageal stricture is frequent acid reflux. Other risk factors include hiatal hernia, obesity, smoking, esophageal dysmotility, increased gastric acidity, and heavy alcohol use.
Risk Factors
Common Risk Factors
- Common risk factors in the development of esophageal stricture include:
- Frequent acid reflux[1]
- Hital hernia[2]
Less Common Risk Factors
- Less common risk factors in the development of esophageal stricture include:
- Obesity[3]
- Smoking[3]
- Esophageal dysmotility in scleroderma and systemic sclerosis[4]
- Increased gastric acidity in zollinger-Ellison syndrome[5]
- Heavy alcohol use[6]
References
- ↑ Marks RD, Richter JE (1993). “Peptic strictures of the esophagus”. Am J Gastroenterol. 88 (8): 1160–73. PMID 8338082.
- ↑ Ott DJ, Gelfand DW, Chen YM, Wu WC, Munitz HA (1985). “Predictive relationship of hiatal hernia to reflux esophagitis”. Gastrointest Radiol. 10 (4): 317–20. PMID 4054494.
- ↑ 3.0 3.1 Smith KJ, O’Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC; et al. (2005). “Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus”. Cancer Epidemiol Biomarkers Prev. 14 (11 Pt 1): 2481–6. doi:10.1158/1055-9965.EPI-05-0370. PMC 1481636. PMID 16284367.
- ↑ Ebert, Ellen C. (2008). “Esophageal disease in progressive systemic sclerosis”. Current Treatment Options in Gastroenterology. 11 (1): 64–69. doi:10.1007/s11938-008-0008-8. ISSN 1092-8472.
- ↑ Luedtke, Pia; Levine, Marc S.; Rubesin, Stephen E.; Weinstein, Donald S.; Laufer, Igor (2003). “Radiologic Diagnosis of Benign Esophageal Strictures: A Pattern Approach”. RadioGraphics. 23 (4): 897–909. doi:10.1148/rg.234025717. ISSN 0271-5333.
- ↑ Chen SH, Wang JW, Li YM (2010). “Is alcohol consumption associated with gastroesophageal reflux disease?”. J Zhejiang Univ Sci B. 11 (6): 423–8. doi:10.1631/jzus.B1000013. PMC 2880354. PMID 20506572.
Natural History, Complications, and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
If left untreated, patients with esophageal stricture may progress to develop pulmonary aspiration, weight loss, and dehydration. Common complications of esophageal stricture include perforation, bleeding, pneumonia, bacteremia. Prognosis is generally good but recurrence of symptoms after dilation are prevalent and usually recurrent dilation is necessary.
Natural History, Complications, and Prognosis
Natural History
- The natural history of benign esophageal strictures starts with gradual dysphagia to solid food and heartburn.[1]
- In some cases of esophageal stricture, symptoms of heartburn disappear when fibrosis is established.[2]
- If left untreated, patients with esophageal stricture may progress to develop:[3]
Complications
Prognosis
- Prognosis is generally good and depends on the cause of esophageal stricture. More than 80-90% of esophageal strictures respond well to endoscopic dilation but one third of patients have recurrent symptoms after one year.[4][6]
- Weight loss is associated with poor prognosis among patients with esophageal stricture.[7]
- Progressive gastroesophageal reflux may lead to extended esophageal stricture which prevent gastric acid to flow back in the esophagus. Loss of previous heartburn is related to more esophageal stricture.[2]
References
- ↑ Repici A, Small AJ, Mendelson A, Jovani M, Correale L, Hassan C, Ridola L, Anderloni A, Ferrara EC, Kochman ML (2016). “Natural history and management of refractory benign esophageal strictures”. Gastrointest. Endosc. 84 (2): 222–8. doi:10.1016/j.gie.2016.01.053. PMID 26828759.
- ↑ 2.0 2.1 Lundell, M.D., Ph.D., Lars. “Reflux esophagitis and peptic strictures”. GI Motility online.
- ↑ Hwang JJ (2017). “Safe and Proper Management of Esophageal Stricture Using Endoscopic Esophageal Dilation”. Clin Endosc. 50 (4): 309–310. doi:10.5946/ce.2017.100. PMC 5565041. PMID 28783923.
- ↑ 4.0 4.1 van Boeckel PG, Siersema PD (2015). “Refractory esophageal strictures: what to do when dilation fails”. Curr Treat Options Gastroenterol. 13 (1): 47–58. doi:10.1007/s11938-014-0043-6. PMC 4328110. PMID 25647687.
- ↑ Liu SY, Xiao P, Li TX, Cao HC, Mao AW, Jiang HS, Cao GS, Liu J, Wang YD, Zhang XS (2016). “Predictor of massive bleeding following stent placement for malignant oesophageal stricture/fistulae: a multicentre study”. Clin Radiol. 71 (5): 471–5. doi:10.1016/j.crad.2016.02.001. PMID 26944699.
- ↑ van Boeckel PG, Siersema PD (2015). “Refractory esophageal strictures: what to do when dilation fails”. Curr Treat Options Gastroenterol. 13 (1): 47–58. doi:10.1007/s11938-014-0043-6. PMC 4328110. PMID 25647687.
- ↑ Berry MF (2014). “Esophageal cancer: staging system and guidelines for staging and treatment”. J Thorac Dis. 6 Suppl 3: S289–97. doi:10.3978/j.issn.2072-1439.2014.03.11. PMC 4037413. PMID 24876933.
Diagnosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Rays | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgical | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH














